Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen told lawmakers the business would consider new talks with insurers in regards to the listing selling prices of Wegovy and copyright should they pledge to help keep the medicines on their formularies. https://ayahealthcareaddress49483.bcbloggers.com/30079272/the-single-best-strategy-to-use-for-healthcare-news